The clinical approaches to the chronic degenerative diseases that drain our resources, and compromise our well-being, have become almost exclusively symptom-focused. The common wisdom is that they are idiopathic with final outcomes to be managed rather than prevented or cured. That they are potentially reversible rarely enters any discussion between doctor and patient. Reversibility of Chronic Disease and Hypersensitivity, Volume 5: Treatment Options of Chemical Sensitivity, the final volume of this set, offers a much different perspective on chronic degenerative disease; one that disputes the idiopathic label attached to most, as well as the usual fatalistic prognosis.
Frawley, J. P., E. C. Hagan, and O. G. Fitzhugh. 1952. A comparative pharmacological and toxicological study of organic phosphate-anticholinesterase compounds. J. Pharmacol. Exp. Ther. 105(2):156–165. Frawley, J. P. and H. N. Fuyat.
... J. J. Schauer, R. J. Sheesley, L. P. Naeher, S. Meinardi, D. R. Blake, E. S. Edgerton, A. G. Russell, M. Clements. 2005. Gaseous and particulate emissions from prescribed burning in Georgia. Environ. Sci. Technol. 39(23):9049–9056.
London, U.K.: Baillière Tindall. Strid, J. and S. Strobel. 2002. The mucosal T cell. In Food Allergy and Intolerance, 2nd edn., eds. J. Brostoff and S. J. Challacombe, p. 103. London, U.K.: Baillière Tindall.
Frawley, J. P., E. C. Hagan, and O. G. Fitzhugh. 1952. A comparative pharmacological and toxicological study of organic phosphate-anticholinesterase compounds. J. Pharmacol. Exp. Ther. 105(2):156–165. Frawley, J. P. and H. N. Fuyat.
Reversibility of Chronic Disease and Hypersensitivity, Volume 5: Treatment Options of Chemical Sensitivity. Taylor and Francis, 2017. 321. “Hazardous Substance Fact Sheet: Ethanolamine.” New Jersey Department of Health and Senior ...
Padmanabhan, V., K. Siefert, S. Ransom, T. Johnson, J. Pinkerton, L. Anderson, L. Tao, and K. Kannan. 2008. Maternal bisphenol-A levels at delivery: A looming problem? J. Perinatol. 28(4):258–263. Ye, X., A. M. Bishop, J. A. Reidy, ...
Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.
The clinical approaches to the chronic degenerative diseases that drain our resources, and compromise our well-being, have become almost exclusively symptom-focused.
Jaen CR, McIlvain H, Pot L, et al: Tailoring tobacco counseling to the competing demands in the clinical encounter. ... Palmer JR, Rosenberg L, Shapiro S: “Low-yield” cigarettes and the risk of nonfatal myocardial infarction in women.
In 1964, the first Surgeon General's report on the effects of smoking on health was released. In the nearly 50 years since, extensive data from thousands of studies have consistently...